| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/25/1997 | CN1152924A Proteins from mammaliam liver and their use in oncology |
| 06/25/1997 | CN1152914A Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents |
| 06/25/1997 | CN1152877A Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 06/25/1997 | CN1152876A Laerimal gland specific emulsions for topical application to ocular tissue |
| 06/25/1997 | CN1152875A Enhanced virus-mediated DNA transfer |
| 06/25/1997 | CN1152874A Copolymer-1 improvements in compositions of copolymers |
| 06/25/1997 | CN1152869A Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 06/25/1997 | CN1152867A Methods and compositions for pulmonary delivery of insulin |
| 06/25/1997 | CN1152579A Method of preparing cyclic vasoactive peptides |
| 06/25/1997 | CN1152468A Slow releasing composition |
| 06/25/1997 | CN1152435A Medicinal products containing antimer pure beta-D-dioxypentacyclic nucleoside |
| 06/25/1997 | CN1035257C Midified plutelet factor-4 |
| 06/25/1997 | CN1035256C Process for preparation of new polypetide compound |
| 06/24/1997 | US5641880 Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
| 06/24/1997 | US5641875 Dna construct encoding immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cell comprising same |
| 06/24/1997 | US5641874 DNA encoding bactericidal/permeability increasing proteins |
| 06/24/1997 | US5641870 Low pH hydrophobic interaction chromatography for antibody purification |
| 06/24/1997 | US5641869 Fractionation on immunoaffinity or ion exchange column, ethanol or ammonium sulfate precipitation, reverse phase liquid chromatography, chromatography on silica or heparin sepharose, chromatofocusing, gel filtration, electrophoresis |
| 06/24/1997 | US5641867 Antitumor agents |
| 06/24/1997 | US5641866 Bcl-2-associated proteins |
| 06/24/1997 | US5641863 Immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cells comprising same |
| 06/24/1997 | US5641862 General method for producing and selecting peptides with specific properties |
| 06/24/1997 | US5641861 μopioid receptor ligands: agonists and antagonists |
| 06/24/1997 | US5641860 A glycoprotein useful in the diagnosis of t-lymphoblastic lymphoma and leukemia |
| 06/24/1997 | US5641837 Method of detecting collagen degradation in vivo |
| 06/24/1997 | US5641803 Injecting regulated dosages over a shorter time period causes less myelosuppression and hematologic toxicity |
| 06/24/1997 | US5641760 Method of treating candida infection |
| 06/24/1997 | US5641756 Synthetic oligonucleotide complementary to nucleic acid specific for human vascular endothelial growth factor |
| 06/24/1997 | US5641754 Antitumor agents |
| 06/24/1997 | US5641752 Methods of using endothelin antagonists |
| 06/24/1997 | US5641751 Polypeptides that bind to tumor necrosis factor-alpha, preventing it from binding to its receptors |
| 06/24/1997 | US5641750 Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product |
| 06/24/1997 | US5641749 Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product |
| 06/24/1997 | US5641747 Treatment of osteopetrotic diseases |
| 06/24/1997 | US5641745 Controlled release biodegradable micro- and nanospheres containing cyclosporin |
| 06/24/1997 | US5641744 Treatment of diabetes mellitus |
| 06/24/1997 | US5641743 Therapeutic compositions and methods for use of heparin-binding brain mitogens |
| 06/24/1997 | US5641687 Contacting body fluid with immunological binding partner which binds to specified crosslinked collagen telopeptide, detecting binding, correlating with collagen degradation |
| 06/24/1997 | US5641680 For gene therapy treatment |
| 06/24/1997 | US5641677 Method of enhancing the immunotherapeutic activity of immune cells by depletion of CD8+ T cells |
| 06/24/1997 | US5641676 Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells |
| 06/24/1997 | US5641673 Polynucleotide molecule encoding trans-splicing ribozyme with rna sequence hybridizing to target rna encoding transcription activator protein fused to sequence to be trans-spliced into target rna, linked to transcription regulator |
| 06/24/1997 | US5641670 Protein production and protein delivery |
| 06/24/1997 | US5641669 Platelet-activating factor acetylhydrolase |
| 06/24/1997 | US5641665 Plasmids suitable for IL-2 expression |
| 06/24/1997 | US5641662 Transfection of lung via aerosolized transgene delivery |
| 06/24/1997 | US5641657 DNA encoding an interleukin-6 splice variant |
| 06/24/1997 | US5641656 Nucleic acids encoding avian interferon (IFN) proteins and recombinant methods using them |
| 06/24/1997 | US5641649 Expression of osteogenic factor OP-1 in cells of spodoptera frugiperda infected with recombinant baculovirus |
| 06/24/1997 | US5641636 Method of predicting fetal membrane rupture based on matrix metalloproteinase-9 activity |
| 06/24/1997 | US5641625 Peptide nucleic acids forming duplex, triplex and other structures with nucleic acids; modulation of protein activity by transcription arrest and initiation; specific site cleavage |
| 06/24/1997 | US5641515 Complex of insulin and polyalkylcyanoacrylate or free-insulin loaded polyalkylcyanoacrylate |
| 06/24/1997 | US5641514 Comprising antibiotic mixed powder consisting of ticarcillin, cafazolin, tobramycin, vancomycin, polymethyl methacrylate powder cement, methyl methacrylate liquid cement |
| 06/24/1997 | US5641497 Gastrointestinal defensins, cDNA sequences and method for the production and use thereof |
| 06/24/1997 | US5641492 Broad spectrum vaccine for immunizing animals against gramnegative bacteria comprising killed suspension of bacterial mutant, detoxified lipopolysaccharide immune modulator, protein and lipid binding carrier |
| 06/24/1997 | US5641485 Caledothricins used in the treatment mycotic diseases |
| 06/24/1997 | US5641484 Introducing to tumor either vector comprising nucleic acid encoding simian virus antigen gene product linked to promoter or liposome complexed to said nucleic acid, wherein production of gene product suppresses tumor growth |
| 06/24/1997 | US5641483 Healing of cutaneous wounds, leg ulcers |
| 06/24/1997 | US5641475 Antiodor, antimicrobial and preservative compositions and methods of using same |
| 06/24/1997 | US5641474 Prevention of autoimmune diseases by aerosol administration of autoantigens |
| 06/24/1997 | US5641473 Treatment of autoimmune diseases by aerosol administration of autoantigens |
| 06/21/1997 | CA2191903A1 Stress proteins |
| 06/19/1997 | WO1997021826A2 Complementary adenoviral vector systems and cell lines |
| 06/19/1997 | WO1997021820A2 A novel protein kinase required for ras signal transduction |
| 06/19/1997 | WO1997021819A1 Novel nagpu |
| 06/19/1997 | WO1997021817A1 Antigenic protein originating in malassezia |
| 06/19/1997 | WO1997021815A2 Antifungal proteins |
| 06/19/1997 | WO1997021814A1 Antifungal proteins |
| 06/19/1997 | WO1997021812A2 Mammalian chemokine ccf8 and chemokine receptor cckr3 |
| 06/19/1997 | WO1997021811A2 Novel tyrosine kinase receptors and ligands |
| 06/19/1997 | WO1997021809A1 Dna sequence encoding the tumor suppressor ing1 |
| 06/19/1997 | WO1997021808A1 Modified vegf antisense oligonucleotides |
| 06/19/1997 | WO1997021807A1 Novel dnas, novel polypeptides and novel antibodies |
| 06/19/1997 | WO1997021732A1 Design of hormone-like antibodies with agonistic and antagonistic functions |
| 06/19/1997 | WO1997021731A1 Assay for and uses of peptide hormone receptor ligands |
| 06/19/1997 | WO1997021730A1 Growth hormone secretagogue receptor family |
| 06/19/1997 | WO1997021728A1 PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b) |
| 06/19/1997 | WO1997021726A1 Agents for promoting bone formation |
| 06/19/1997 | WO1997021685A1 Retroviral protease inhibiting compounds |
| 06/19/1997 | WO1997021450A1 Ox-2 costimulatory molecule |
| 06/19/1997 | WO1997021449A1 Method for effecting changes in the central nervous system by administration of igf-i or igf-ii |
| 06/19/1997 | WO1997021448A1 A calcitonin preparation |
| 06/19/1997 | WO1997021447A1 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| 06/19/1997 | WO1997021446A1 Pharmaceutical composition for protection of hematopoietic progenitor cells and uses |
| 06/19/1997 | WO1997021445A1 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 06/19/1997 | WO1997021444A1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof |
| 06/19/1997 | WO1997021443A1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof |
| 06/19/1997 | WO1997017434A3 The use of lecithin-cholesterol acyltransferase (lcat) in the treatment of atherosclerosis |
| 06/19/1997 | WO1997017086A3 Composition for improving pancreatic function |
| 06/19/1997 | WO1997016549A3 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 06/19/1997 | WO1997016221A3 Genetic induction of receptors for targeted radiotherapy |
| 06/19/1997 | WO1997006662A3 Inverted chimeric and hybrid oligonucleotides |
| 06/19/1997 | WO1996024650A3 Cytoplasmic antiproteinase-2 and cytoplasmic antiproteinase-3 and coding sequences |
| 06/19/1997 | DE19629119A1 Gegen Bakterien, Mycota und Viren wirksame kosmetische Zubereitungen enthaltend Vertebratenproteine Against bacteria, viruses mycota and effective cosmetic preparations containing Vertebratenproteine |
| 06/19/1997 | DE19547105A1 Treatment of dental and nasal problems and herpes infections |
| 06/19/1997 | DE19546938A1 New carbamoyl substituted piperidine carbonyl peptide derivatives |
| 06/19/1997 | DE19545257A1 Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln A process for the production of morphologically uniform microcapsules and microcapsules prepared by this method |
| 06/19/1997 | CA2509505A1 Retroviral protease inhibiting compounds |
| 06/19/1997 | CA2239993A1 Dna sequence encoding the tumor suppressor ing1 |
| 06/19/1997 | CA2239991A1 Modified vegf antisense oligonucleotides |